HOT OFFER Clinical Rotation Special: 100+ Done-For-You Care Plans in Editable Word/Docs Format + 25 Shift Brain Sheets. Get Instant Access ($27) →
Sprout Path · Clinical Nursing Reference Series

Interactive Nursing Care Plans Library

Search evidence-based NANDA-I nursing diagnoses, SMART NOC outcomes, and prioritized NIC interventions with physiological rationales. Designed for clinical rotations, simulation prep, and shift documentation.

Showing 19 Clinical Care Plans 💡 Click "Copy Care Plan" to paste clean, formatted text into clinical forms or notes.
Respiratory / Cardiopulmonary NANDA-I Standard

Impaired Gas Exchange: COPD Exacerbation

PES Statement: Impaired Gas Exchange related to alveolar-capillary membrane changes, air trapping, and ventilation-perfusion mismatch secondary to chronic obstructive pulmonary disease exacerbation as evidenced by arterial blood gas showing PaO2 54 mmHg and PaCO2 62 mmHg, SpO2 83% on room air, respiratory rate 28 breaths/min, tripod positioning, pursed-lip breathing, and patient report of severe air hunger.

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient states: 'I feel like I cannot catch my breath even when sitting completely still.'
  • Patient reports severe throbbing frontal headache upon awakening.
  • Patient states: 'I am completely exhausted from fighting for every single breath.'
Objective Cues
  • SpO2: 83% on room air; PaO2: 54 mmHg; PaCO2: 62 mmHg; arterial pH: 7.31.
  • Respiratory Rate: 28 breaths/min with prominent scalene and intercostal retractions.
  • Auscultation: Distant breath sounds with prolonged expiratory wheezing bilaterally and basilar crackles.
  • Inspection: Seated in orthopneic tripod position leaning on overbed table; facial flushing; digital clubbing.

NOC Expected Outcomes (SMART Goals)

  • Short-Term (Within 2 Hours): Patient will achieve and maintain SpO2 between 88% and 92% on titrated Venturi mask oxygen therapy. Target: SpO2 88-92%, RR 16-22 breaths/min
  • Short-Term (By End of 12-Hour Shift): Patient will demonstrate arterial blood gas stabilization toward chronic baseline (pH ≥ 7.35, PaO2 ≥ 60 mmHg) with absence of somnolence or flapping asterixis. Target: pH ≥ 7.35, Alert & Oriented x4
  • Long-Term (By Discharge / Day 4): Patient will independently demonstrate pursed-lip breathing during ambulation and verbalize three red-flag signs of CO2 narcosis requiring emergency contact. Target: 100% teach-back on pursed-lip breathing and red-flag symptoms

NIC Interventions & Physiological Rationales

Independent Action

Intervention: Position patient in High-Fowler's or orthopneic tripod position leaning forward supported by a padded bedside table.

Rationale: Leaning forward stabilizes the shoulder girdle, allowing accessory muscles (pectoralis major/minor) to assist chest expansion while gravity pulls abdominal viscera away from the diaphragm, increasing functional residual capacity.

Independent Action

Intervention: Coach patient in Pursed-Lip Breathing (inhale 2 seconds through nose, exhale slowly 4 seconds through pursed lips).

Rationale: Exhaling against pursed lips generates intrinsic positive end-expiratory pressure (PEEP) in proximal airways, preventing dynamic airway collapse during exhalation and facilitating CO2 exhalation.

Independent Action

Intervention: Cluster physical care activities and schedule 30-minute uninterrupted rest periods between nursing interventions.

Rationale: Severe respiratory distress diverts up to 40% of cardiac output solely to respiratory muscle work; clustering care conserves metabolic oxygen consumption (VO2).

Collaborative Action

Intervention: Administer titrated oxygen therapy via 28% Venturi mask, maintaining SpO2 strictly between 88% and 92%.

Rationale: Venturi masks deliver a precise FiO2 independent of patient breathing pattern, preventing severe hypoxemia while avoiding loss of hypoxic pulmonary vasoconstriction and excessive hypercapnic worsening.

Collaborative Action

Intervention: Administer prescribed short-acting beta-2 agonist (albuterol 2.5 mg) and anticholinergic (ipratropium 0.5 mg) via nebulizer Q4-6H PRN.

Rationale: Albuterol stimulates beta-2 receptors causing rapid bronchial smooth muscle relaxation; ipratropium blocks cholinergic bronchoconstriction and reduces goblet-cell mucus production.

Collaborative Action

Intervention: Administer prescribed systemic corticosteroid (methylprednisolone 40 mg IV Q12H) and monitor capillary blood glucose.

Rationale: Glucocorticoids suppress bronchial mucosal inflammatory cascades, reducing bronchial hyperreactivity and edema.

Patient Teaching Action

Intervention: Instruct patient on proper Metered-Dose Inhaler (MDI) technique using a valved holding chamber (spacer), followed by warm water oral gargling.

Rationale: Spacers eliminate breath-actuation coordination errors, increasing pulmonary drug deposition by over 30% while oral rinsing prevents oropharyngeal candidiasis (thrush).

Evaluation Criteria

Respiratory / Med-Surg NANDA-I Standard

Impaired Gas Exchange: Severe Community-Acquired Pneumonia

PES Statement: Impaired Gas Exchange related to alveolar exudate accumulation, alveolar-capillary membrane inflammation, and intrapulmonary shunting secondary to acute bacterial lobar pneumonia as evidenced by arterial blood gas showing severe hypoxemia (PaO2 52 mmHg), SpO2 85% on room air, respiratory rate 30 breaths/min, pleuritic right-sided chest pain, and dense right lower lobe consolidation on chest radiograph.

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient states: 'Every breath feels like a hot knife stabbing my right chest.'
  • Patient states: 'I cannot stop shaking from chills and cannot catch my breath.'
  • Patient reports coughing up thick, rust-colored mucus.
Objective Cues
  • SpO2: 85% on room air; arterial blood gas: pH 7.48, PaCO2 30 mmHg, PaO2 52 mmHg.
  • Respiratory Rate: 30 breaths/min; Heart Rate: 112 bpm; Temp: 39.2°C (102.6°F).
  • Auscultation: Dense coarse inspiratory crackles and bronchial breath sounds over right middle and lower lobes; dullness to percussion.
  • Diagnostics: Chest radiograph demonstrates right lower lobe lobar consolidation with air bronchograms; WBC 18,400/mcL with left shift.

NOC Expected Outcomes (SMART Goals)

  • Short-Term (Within 2 Hours): Patient will achieve and maintain SpO2 ≥ 94% on nasal cannula oxygen therapy (≤ 4 L/min) with respiratory rate decreasing to < 24 breaths/min. Target: SpO2 ≥ 94%, RR < 24/min
  • Short-Term (Within 24 Hours): Patient's temperature will decrease to < 38.0°C (100.4°F) and arterial PaO2 will stabilize at ≥ 75 mmHg. Target: Temp < 38.0°C, PaO2 ≥ 75 mmHg
  • Long-Term (By Discharge / Day 5): Patient will maintain SpO2 ≥ 94% on room air at rest and during 50-foot hall ambulation without pleuritic chest pain. Target: SpO2 ≥ 94% on RA, ambulate 50 ft

NIC Interventions & Physiological Rationales

Independent Action

Intervention: Position patient with the 'Good Lung Down' (left lateral recumbent position) when side-lying.

Rationale: Gravity directs pulmonary blood flow to dependent lung regions. Placing the healthy, unaffected left lung dependent maximizes perfusion to ventilated alveoli, optimizing V/Q ratio and decreasing anatomical right-to-left shunt.

Independent Action

Intervention: Coach and assist patient with Incentive Spirometry (10 sustained deep inhalations per hour while awake).

Rationale: Slow, maximal sustained inspiration recruits collapsed terminal alveoli, expands surface area for capillary gas diffusion, and stimulates surfactant release.

Collaborative Action

Intervention: Obtain two sets of peripheral blood cultures and sputum Gram stain/culture prior to starting prescribed intravenous antibiotics.

Rationale: Isolating the pathogen prior to antibiotic administration ensures accurate antimicrobial sensitivity profiles and targeted de-escalation.

Collaborative Action

Intervention: Administer prescribed intravenous antimicrobial therapy (ceftriaxone 1 g IV daily + azithromycin 500 mg IV daily) within 2 hours of admission.

Rationale: Prompt antimicrobial therapy halts bacterial replication in the alveolar space, decreases neutrophil accumulation, and reduces sepsis mortality.

Collaborative Action

Intervention: Administer prescribed antipyretic (acetaminophen 650 mg PO/IV Q6H PRN for temperature > 38.3°C).

Rationale: Every 1°C increase in core body temperature elevates cellular oxygen consumption (VO2) by 10-13%, worsening systemic hypoxemia.

Patient Teaching Action

Intervention: Instruct patient on completing the full course of oral step-down antibiotics and recommend pneumococcal (PCV20) vaccination upon recovery.

Rationale: Prevents bacterial relapse and development of antibiotic-resistant strains; conjugate vaccination prevents future invasive pneumococcal pneumonia.

Evaluation Criteria

Respiratory / Med-Surg NANDA-I Standard

Ineffective Airway Clearance: Retained Secretions

PES Statement: Ineffective Airway Clearance related to retained tracheobronchial secretions, excessive mucus viscosity, and neuromuscular cough weakness secondary to tracheobronchitis and cerebrovascular frailty as evidenced by audible moist gurgling, diffuse coarse rhonchi on auscultation, weak non-productive cough, tenacious green mucus, and SpO2 89% on room air.

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient nods affirmatively when asked if phlegm feels stuck in the throat.
  • Family reports: 'He sounds like he is choking on saliva and cannot cough it out.'
Objective Cues
  • Audible moist gurgling respirations heard at bedside without stethoscope.
  • Auscultation: Diffuse coarse rhonchi and low-pitched sonorous wheezing bilaterally.
  • Cough effort: Shallow, weak, ineffective, non-productive.
  • SpO2: 89% on room air; drops to 86% during coughing attempts; thick green secretions pooled in posterior pharynx.

NOC Expected Outcomes (SMART Goals)

  • Short-Term (Within 2 Hours): Patient will demonstrate airway patency evidenced by clearing coarse rhonchi following assisted airway clearance techniques and maintaining SpO2 ≥ 93% on prescribed oxygen. Target: SpO2 ≥ 93%, Rhonchi cleared
  • Short-Term (Within 12 Hours): Patient or nurse will mobilize and expectorate or suction ≥ 15 mL of tracheobronchial secretions, resulting in clear breath sounds over upper fields. Target: ≥ 15 mL secretions mobilized
  • Long-Term (By Discharge / Day 4): Caregiver will independently demonstrate safe oral suctioning technique and use of oscillating positive expiratory pressure (Acapella) device. Target: 100% caregiver teach-back

NIC Interventions & Physiological Rationales

Independent Action

Intervention: Teach and guide patient through 'Huff Coughing' (Forced Expiratory Technique: take medium breath, exhale 3 rapid breaths saying 'huff, huff, huff' with glottis open).

Rationale: Open-glottis huff coughing maintains airway lumen caliber, preventing the airway collapse caused by explosive closed-glottis coughing and shearing mucus from bronchial walls.

Independent Action

Intervention: Reposition patient Q2H from side to side and elevate head of bed 45-60 degrees.

Rationale: Postural alteration uses gravity to drain secretions from peripheral broncho-segments into central bronchi where they can be suctioned or coughed out.

Collaborative Action

Intervention: Administer prescribed nebulized hypertonic saline (3%) or acetylcysteine Q6H.

Rationale: Hypertonic saline draws water osmotically into the airway lumen, while acetylcysteine cleaves disulfide mucoprotein bonds, drastically reducing mucus viscosity.

Collaborative Action

Intervention: Utilize an Oscillating Positive Expiratory Pressure (O-PEP / Acapella) device 4 times daily.

Rationale: Generates 15-20 Hz acoustic vibrations that thin mucus while positive pressure splints airways open during exhalation.

Collaborative Action

Intervention: Perform oropharyngeal suctioning with Yankauer catheter PRN, limiting passes to < 10 seconds and hyperoxygenating beforehand.

Rationale: Removes pooled secretions when voluntary cough fails; brief intervals prevent severe vagal-mediated bradycardia and hypoxemia.

Patient Teaching Action

Intervention: Instruct family never to offer liquids or food while patient is lying flat or somnolent.

Rationale: Impaired pharyngeal sensation and supine positioning disable the swallow reflex, precipitating fatal laryngeal aspiration.

Evaluation Criteria

Respiratory / Cardiopulmonary NANDA-I Standard

Ineffective Breathing Pattern: Acute Asthma Exacerbation

PES Statement: Ineffective Breathing Pattern related to tracheobronchial hyperreactivity, acute bronchospasm, and respiratory muscle exhaustion secondary to severe asthma exacerbation as evidenced by severe tachypnea (34 breaths/min), Peak Expiratory Flow Rate at 37.5% of personal best (Red Zone), suprasternal and intercostal retractions, prolonged expiratory phase, and ability to speak only in 1-word fragmented phrases.

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient gasps: 'Can't... breathe... chest... tight...' (1-word broken phrases).
  • Patient exhibits extreme terror, wide eyes, and severe restlessness.
Objective Cues
  • Respiratory Rate: 34 breaths/min; Heart Rate: 124 bpm (sinus tachycardia); BP: 144/88 mmHg.
  • Auscultation: High-pitched, musical expiratory and inspiratory wheezes throughout all lobes; marked prolongation of expiratory phase.
  • Inspection: Seated upright leaning forward (tripod stance); deep suprasternal, supraclavicular, and intercostal retractions.
  • Diagnostics: Peak Expiratory Flow Rate (PEFR): 180 L/min (baseline personal best: 480 L/min — 37.5%, severe Red Zone); SpO2: 90% on room air.

NOC Expected Outcomes (SMART Goals)

  • Short-Term (Within 1 Hour): Patient's respiratory rate will decrease from 34 to < 22 breaths/min with noticeable reduction in accessory muscle retractions following continuous nebulized bronchodilators. Target: RR < 22/min, Retractions decreased
  • Short-Term (Within 4 Hours): Patient's Peak Expiratory Flow Rate will increase to ≥ 70% of personal best (> 336 L/min) and SpO2 will stabilize at ≥ 95% on room air. Target: PEFR ≥ 70%, SpO2 ≥ 95% RA
  • Long-Term (By Discharge): Patient will independently explain the 3 zones of their personalized Asthma Action Plan and demonstrate proper maintenance and priming of their rescue MDI. Target: 100% Asthma Action Plan teach-back

NIC Interventions & Physiological Rationales

Independent Action

Intervention: Maintain a calm, unhurried presence at the bedside and coach patient through slow, rhythmic nasal breathing and pursed exhalation.

Rationale: Panic triggers sympathetic adrenergic surge, worsening tachypnea and increasing dead space ventilation, accelerating respiratory muscle exhaustion.

Independent Action

Intervention: Position patient in High-Fowler's (90 degrees upright) or seated leaning over a bedside table.

Rationale: Allows full gravitational descent of the diaphragm, maximizing thoracic expansion against constricted airways.

Independent Action

Intervention: Continuously monitor for the ominous 'Silent Chest' sign (sudden cessation of audible wheezing with persistent retractions).

Rationale: Disappearance of wheezing without clinical improvement indicates complete airflow arrest, signaling imminent asphyxiation and emergency intubation.

Collaborative Action

Intervention: Administer high-dose short-acting beta-2 agonist (albuterol 5 mg) combined with ipratropium (0.5 mg) via continuous or back-to-back jet nebulizers.

Rationale: Continuous nebulization saturates bronchial beta-2 receptors, activating intracellular cAMP and reversing bronchospasm rapidly.

Collaborative Action

Intervention: Administer prescribed systemic corticosteroid (IV methylprednisolone 60 mg or oral prednisone 50 mg).

Rationale: Downregulates pro-inflammatory gene transcription, reversing bronchial mucosal edema within 4 to 6 hours.

Collaborative Action

Intervention: Administer prescribed IV Magnesium Sulfate (2 g in 100 mL D5W over 20 minutes) for refractory bronchospasm.

Rationale: Acts as a physiological calcium antagonist, blocking calcium influx into bronchial smooth muscle cells to induce rapid bronchodilation.

Patient Teaching Action

Intervention: Review Asthma Action Plan zones: Green (≥ 80%), Yellow (50-79%), Red (< 50% - immediate emergency care).

Rationale: Daily peak flow tracking detects subclinical airway narrowing days before physical symptoms emerge, preventing fatal delayed presentations.

Evaluation Criteria

Cardiovascular / Perfusion NANDA-I Standard

Decreased Cardiac Output: Decompensated Heart Failure (HFrEF)

PES Statement: Decreased Cardiac Output related to impaired myocardial contractility, ventricular remodeling, and elevated afterload secondary to acute decompensated heart failure with reduced ejection fraction (HFrEF) as evidenced by Left Ventricular Ejection Fraction of 22%, elevated BNP (1,650 pg/mL), S3 ventricular gallop, JVD 7 cm, bilateral 3+ peripheral edema, hypotension (98/62 mmHg), tachycardia (114 bpm), delayed capillary refill (4 seconds), and severe orthopnea.

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient states: 'I feel like I am drowning when I lie flat; I have to sleep upright in a chair.'
  • Patient states: 'I am so dizzy and weak I can barely take three steps.'
  • Patient reports sudden swelling in ankles and 8-pound weight gain in 4 days.
Objective Cues
  • Echocardiogram: LVEF 22% with global hypokinesis; BNP: 1,650 pg/mL; S3 gallop at apex.
  • Vital Signs: BP 98/62 mmHg; HR 114 bpm (sinus tachycardia with PVCs); RR 26/min; SpO2 89% RA.
  • Physical Exam: Bilateral 3+ lower extremity pitting edema; JVD 7 cm above sternal angle at 45°; moist bibasilar crackles.
  • Perfusion Markers: Capillary refill 4 seconds; cool, pale, clammy extremities; oliguria (20 mL/hr).

NOC Expected Outcomes (SMART Goals)

  • Short-Term (Within 4 Hours): Patient will achieve adequate end-organ perfusion evidenced by urine output ≥ 30 mL/hr and Mean Arterial Pressure (MAP) ≥ 65 mmHg following IV diuretic administration. Target: Urine output ≥ 30 mL/hr, MAP ≥ 65 mmHg
  • Short-Term (Within 24 Hours): Patient will experience a net negative fluid balance of 1,500 to 2,000 mL with resolution of pulmonary crackles and reduction in dyspnea score from 8/10 to ≤ 3/10. Target: Net balance -1500 to -2000 mL, Crackles cleared
  • Long-Term (By Discharge / Day 5): Patient will return to euvolemic dry weight, demonstrate zero orthopnea, and recite the 2-2-5 daily weight protocol. Target: 100% teach-back on daily weights and 2g sodium diet

NIC Interventions & Physiological Rationales

Independent Action

Intervention: Position patient in Semi-Fowler's to High-Fowler's (30-45 degrees elevation) with legs dependent or slightly supported.

Rationale: Reduces venous return (preload) to the volume-overloaded failing left ventricle, lowering left ventricular wall stress and pulmonary capillary hydrostatic pressure.

Independent Action

Intervention: Perform strict I&O recording and obtain daily weights at 07:00 on the same calibrated scale after first morning void.

Rationale: One liter of retained fluid equals 1.0 kg (2.2 lbs); daily weights are the most sensitive clinical indicator of acute fluid shifts.

Independent Action

Intervention: Enforce cardiac rest and cluster nursing activities.

Rationale: Minimizes systemic catecholamine release and reduces myocardial oxygen consumption (MVO2) in a heart with 22% ejection fraction.

Collaborative Action

Intervention: Administer prescribed IV loop diuretic (furosemide 40-80 mg IV push slowly over 2-4 minutes) and monitor hourly urine output.

Rationale: Inhibits Na-K-2Cl cotransporters in the thick ascending loop of Henle, producing profound natriuresis, while initial venodilation lowers cardiac preload within 15 minutes.

Collaborative Action

Intervention: Monitor serum potassium, magnesium, BUN, and creatinine every 12-24 hours during diuresis.

Rationale: Loop diuresis causes severe urinary potassium/magnesium loss, which precipitates lethal ventricular dysrhythmias in ischemic myocardium.

Collaborative Action

Intervention: Titrate prescribed ARNI (sacubitril/valsartan) and beta-blocker once euvolemic, holding for SBP < 90 mmHg or HR < 60 bpm.

Rationale: Inhibits neprilysin to raise endogenous natriuretic peptides, blocks AT1 receptors to reduce afterload, and blocks toxic chronic sympathetic stimulation.

Patient Teaching Action

Intervention: Teach the '2-2-5 Rule': Weigh every morning before breakfast; call provider immediately if weight increases > 2 lbs in 24 hours or > 5 lbs in 1 week.

Rationale: Detects fluid accumulation 48-72 hours before overt dyspnea appears, allowing outpatient diuretic adjustments and preventing readmissions.

Patient Teaching Action

Intervention: Instruct on strict 2,000 mg/day (2 g) sodium restriction and 1.5 L/day fluid limit.

Rationale: Prevents osmotic intravascular water retention that overwhelms compromised renal excretory capacity.

Evaluation Criteria

Cardiovascular / Perfusion NANDA-I Standard

Ineffective Peripheral Tissue Perfusion: Peripheral Artery Disease

PES Statement: Ineffective Peripheral Tissue Perfusion related to atherosclerotic arterial lumen narrowing, systemic plaque deposition, and reduced peripheral arterial blood flow secondary to severe Peripheral Artery Disease (PAD) as evidenced by bilateral Ankle-Brachial Index < 0.65, non-palpable pedal pulses, marked elevation pallor and dependent rubor, severe calf claudication pain at < 1 block, delayed capillary refill (> 4 seconds), and ischemic rest pain.

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient states: 'My calves cramp up like a vice every time I walk half a block.'
  • Patient states: 'My feet burn and ache so terribly at night that I have to hang my legs off the bed to sleep.'
  • Patient reports toes and feet always feel freezing cold.
Objective Cues
  • Diagnostics: Resting Ankle-Brachial Index (ABI): Right 0.58, Left 0.62 (moderate to severe arterial disease).
  • Pulses: Dorsalis pedis and posterior tibial pulses absent to palpation bilaterally; audible only via Doppler (1+ faint biphasic).
  • Skin & Trophic Changes: Pale, shiny, hairless skin on shins and feet; thickened, brittle toenails; skin cool to mid-calf.
  • Positional Color Changes: Marked elevation pallor at 60 seconds; deep dependent rubor within 30 seconds of dangling; capillary refill > 4 seconds.

NOC Expected Outcomes (SMART Goals)

  • Short-Term (Within 24 Hours): Patient will achieve relief of ischemic rest pain (≤ 2/10 numeric score) through dependent lower extremity positioning and prescribed medications. Target: Pain score ≤ 2/10
  • Short-Term (Within 48 Hours): Patient will independently demonstrate daily foot inspection with a long-handled mirror and articulate five thermal safety rules. Target: 100% foot inspection teach-back
  • Long-Term (By Follow-Up Week 4): Patient will participate in a structured graduated walking program, increasing pain-free claudication walking distance by ≥ 50%. Target: ≥ 50% increase in walking distance

NIC Interventions & Physiological Rationales

Independent Action

Intervention: Instruct and position patient to keep lower extremities DEPENDENT (dangling or flat); NEVER elevate above the level of the heart.

Rationale: Arterial blood must overcome stenotic resistance. Dangling utilizes gravity to increase hydrostatic arterial perfusion pressure, relieving ischemic pain.

Independent Action

Intervention: Strictly prohibit the application of heating pads, hot water bottles, or hot soaks to the lower extremities.

Rationale: Ischemic tissue has reduced sensory nerve perception and cannot increase blood flow to dissipate heat, leading to severe thermal burns and gangrene.

Independent Action

Intervention: Inspect feet, interdigital spaces, and heels daily for pale, punched-out ischemic ulcers, skin cracks, or erythema.

Rationale: Severe arterial insufficiency impairs local immune delivery, allowing minor micro-trauma to rapidly progress to osteomyelitis or gangrene.

Collaborative Action

Intervention: Administer prescribed antiplatelet therapy (aspirin 81 mg daily or clopidogrel 75 mg daily).

Rationale: Irreversibly inhibits platelet aggregation, preventing acute arterial thrombosis over ruptured atherosclerotic plaques.

Collaborative Action

Intervention: Administer prescribed phosphodiesterase-3 inhibitor (cilostazol 100 mg PO BID 30 min before meals).

Rationale: Inhibits PDE-3, raising intracellular cAMP to produce arterial vasodilation and inhibit platelet aggregation, improving claudication distance.

Collaborative Action

Intervention: Assess pedal pulses Q-shift using a handheld continuous-wave Doppler probe and record signal waveform.

Rationale: Provides objective acoustic verification of arterial patency and detects acute thromboembolic graft or vessel occlusion.

Patient Teaching Action

Intervention: Teach graduated walking exercise protocol: Walk until moderate claudication pain occurs (3-4/10), stop and rest until pain completely resolves, then resume walking for 30-45 minutes.

Rationale: Walking to the ischemic threshold induces local hypoxia, stimulating VEGF release and promoting collateral vessel angiogenesis.

Patient Teaching Action

Intervention: Provide urgent smoking cessation counseling and arrange immediate pharmacotherapy referral.

Rationale: Nicotine induces severe peripheral vasoconstriction, reduces cutaneous blood flow by up to 40%, and is the single greatest risk factor for amputation.

Evaluation Criteria

Cardiovascular / Fluid Balance NANDA-I Standard

Excess Fluid Volume: Congestive Hypervolemia

PES Statement: Excess Fluid Volume related to compromised regulatory mechanisms, secondary hyperaldosteronism, and renal sodium/water retention secondary to cardiovascular failure as evidenced by an acute 9-pound weight gain in 5 days, bilateral 3+ to 4+ pitting lower extremity edema with skin weeping, JVD 8 cm, abdominal ascites, hypertension (164/94 mmHg), and bilateral basilar crackles.

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient states: 'My legs are so swollen the skin feels like it is about to burst open.'
  • Patient states: 'I've gained 9 pounds since Thursday and my stomach feels bloated and tight.'
Objective Cues
  • Weight gain: 4.1 kg (9.0 lbs) in 5 days; Blood Pressure: 164/94 mmHg.
  • Physical Exam: Bilateral 3+ to 4+ pitting edema extending to mid-thighs with serous fluid weeping over pretibial surfaces; JVD 8 cm at 45°.
  • Abdomen: Distended with positive fluid wave (ascites); fine inspiratory crackles auscultated in bilateral bases.
  • Diagnostics: Serum Sodium: 132 mEq/L (dilutional hyponatremia); CXR: cardiomegaly with pulmonary vascular cephalization.

NOC Expected Outcomes (SMART Goals)

  • Short-Term (Within 24 Hours): Patient will achieve a net negative fluid balance of ≥ 2,000 mL with urinary output exceeding 100 mL/hr during active IV loop diuresis. Target: Net balance ≥ -2000 mL, UO > 100 mL/hr
  • Short-Term (Within 48 Hours): Patient's lower extremity edema will decrease from 4+ to ≤ 1+ with complete cessation of pretibial serous skin weeping. Target: Edema ≤ 1+, Weeping ceased
  • Long-Term (By Discharge / Day 5): Patient will reach target dry weight, maintain BP < 130/80 mmHg, and demonstrate ability to log daily fluid intake within 1,500 mL limit. Target: Dry weight reached, 100% fluid log teach-back

NIC Interventions & Physiological Rationales

Independent Action

Intervention: Enforce strict 1,500 mL/24-hour fluid restriction distributed across shifts (700 mL Day, 600 mL Evening, 200 mL Night).

Rationale: Directly halts intravascular volume expansion, corrects dilutional hyponatremia, and lowers capillary hydrostatic pressure.

Independent Action

Intervention: Elevate lower extremities above heart level when seated or supine (once acute orthopnea is stabilized).

Rationale: Promotes gravitational lymphatic and venous drainage from interstitial tissues into central circulation for renal filtration.

Independent Action

Intervention: Provide meticulous skin care over edematous tissue: apply barrier creams, avoid adhesives, and apply sterile moisture-wicking dressings to weeping areas.

Rationale: Severe edema distends epidermal cells, impairs cutaneous microcirculation, and exponentially elevates cellulitis and skin-tear risk.

Collaborative Action

Intervention: Administer continuous IV furosemide infusion (10 mg/hr following 40 mg bolus) or scheduled IV bumetanide.

Rationale: Continuous loop diuretic delivery maintains steady drug concentration at tubular receptor sites, preventing post-dosing rebound sodium retention.

Collaborative Action

Intervention: Monitor serum electrolytes (potassium, sodium, magnesium) and renal function panels Q12-24H.

Rationale: Aggressive loop diuresis accelerates urinary potassium and magnesium wasting, risking metabolic alkalosis and lethal cardiac ectopy.

Patient Teaching Action

Intervention: Instruct on identifying hidden liquids: ice cream, gelatin, soups, and explain that a cup of ice chips melts to 50% liquid volume.

Rationale: Prevents inadvertent excess fluid consumption from overlooked semi-solid dietary items.

Evaluation Criteria

Surgical / Comfort NANDA-I Standard

Acute Pain: Post-Operative Abdominal Surgery

PES Statement: Acute Pain related to surgical tissue trauma, mechanical dissection, and inflammatory mediator release secondary to open exploratory laparotomy as evidenced by patient rating pain 8/10 on the numeric rating scale, guarding of abdominal incision, shallow tachypneic breathing (26 breaths/min), reluctance to cough or ambulate, diaphoresis, and hypertension (158/92 mmHg).

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient states: 'My stomach feels like it is on fire; it hurts 8 out of 10.'
  • Patient states: 'I cannot cough or move because I feel like my stitches will rip open.'
Objective Cues
  • Pain rating: 8/10 on 0-10 Numeric Rating Scale.
  • Physical Exam: Rigid abdominal splinting; patient lying rigid with knees pulled up; grimacing with any movement.
  • Vital Signs: Blood Pressure: 158/92 mmHg; Heart Rate: 104 bpm; Respiratory Rate: 26 breaths/min (shallow).
  • Incentive Spirometry: Inhales only 400 mL before stopping due to incisional sharp pain.

NOC Expected Outcomes (SMART Goals)

  • Short-Term (Within 45 Minutes): Patient will report pain reduction to a tolerable level (≤ 3/10 on numeric rating scale) following multimodal analgesia and positioning. Target: Pain ≤ 3/10
  • Short-Term (Within 4 Hours): Patient will demonstrate effective deep breathing and incentive spirometry volume ≥ 1,000 mL with proper incisional splinting. Target: Incentive spirometry ≥ 1,000 mL
  • Long-Term (By Post-Op Day 3): Patient will independently transition to oral multimodal analgesics, ambulate 150 feet in the hallway, and report pain controlled at ≤ 3/10. Target: Ambulate 150 ft, Oral analgesia

NIC Interventions & Physiological Rationales

Independent Action

Intervention: Teach and assist patient with incisional splinting using a folded bath blanket or firm pillow pressed firmly against the abdomen during coughing, deep breathing, and turning.

Rationale: External counter-pressure counteracts abdominal wall distraction forces during diaphragmatic movement, drastically reducing incisional tension and pain.

Independent Action

Intervention: Position patient in low-Fowler's with knees slightly flexed using a knee gatch or under-knee pillow.

Rationale: Flexing the knees relaxes the rectus abdominis and psoas muscles, removing tension across the surgical suture line.

Collaborative Action

Intervention: Administer prescribed IV opioid multimodal analgesia (e.g., hydromorphone 0.5-1 mg IV push Q3H PRN) combined with scheduled IV acetaminophen (1,000 mg Q6H).

Rationale: Opioids bind mu-opioid receptors in the central nervous system to alter pain perception, while IV acetaminophen acts centrally via prostaglandin inhibition, producing opioid-sparing synergy.

Collaborative Action

Intervention: Assess respiratory rate, SpO2, and sedation score using the Richmond Agitation-Sedation Scale (RASS) or Pasero Opioid-Induced Sedation Scale (POSS) before and 20 minutes after IV opioid administration.

Rationale: Opioid-induced respiratory depression is invariably preceded by increasing somnolence; systematic sedation monitoring prevents fatal hypoventilation.

Patient Teaching Action

Intervention: Instruct patient to request pain medication before pain reaches severe levels (> 4/10) rather than trying to endure it.

Rationale: Preemptive analgesia prevents central sensitization ('wind-up' phenomenon), allowing effective postoperative pulmonary hygiene and early mobilization.

Evaluation Criteria

Geriatric / Safety NANDA-I Standard

Risk for Falls: Geriatric Frailty & Polypharmacy

PES Statement: Risk for Falls as evidenced by age 84 years, history of two falls in preceding 6 months, Morse Fall Score of 75 (High Risk), generalized lower extremity sarcopenia, orthostatic blood pressure drop of 24 mmHg, administration of central nervous system sedatives and loop diuretics, and unfamiliar hospital environment.

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient states: 'Sometimes my knees just give out on me when I get up to pee at night.'
  • Daughter states: 'She has fallen twice at home in the last six months, once bruising her hip.'
Objective Cues
  • Morse Fall Scale: 75 (High Risk tier; threshold for high risk is ≥ 45).
  • Timed Up and Go (TUG) Test: 22 seconds (normal for community-dwelling adult is < 12 seconds).
  • Orthostatic Vitals: Lying BP 138/80, HR 72; Standing (3 min) BP 114/68, HR 88 (systolic drop of 24 mmHg confirming orthostatic hypotension).
  • Medications: Furosemide 40 mg daily, Zolpidem 5 mg at bedtime, Gabapentin 300 mg TID, Lisinopril 20 mg daily.

NOC Expected Outcomes (SMART Goals)

  • Short-Term (Throughout Inpatient Stay): Patient will experience zero in-hospital falls or fall-related physical injuries. Target: Zero falls recorded
  • Short-Term (Within 12 Hours): Patient will consistently utilize call light for all unassisted bed transfers and demonstrate 1-minute seated dangle prior to standing. Target: 100% call light compliance, Dangle demonstration
  • Long-Term (By Discharge / Day 4): Caregiver will verbalize home environmental safety modifications (removing throw rugs, installing bathroom grab bars, nightlights) and safe walker technique. Target: 100% teach-back on home safety

NIC Interventions & Physiological Rationales

Independent Action

Intervention: Implement High Fall Risk Bundle: Apply yellow non-skid socks, place yellow fall-risk armband, position bed in lowest locked position, and activate bed exit motion alarm.

Rationale: Multi-component safety bundles provide visual reminders for hospital staff while immediate auditory alarm alerts nursing before an unassisted transfer results in impact.

Independent Action

Intervention: Establish a proactive scheduled rounding protocol ('4 Ps': Pain, Position, Potty, Possessions) every 1 hour during the day and every 2 hours at night.

Rationale: Over 60% of inpatient geriatric falls occur during unassisted attempts to reach the toilet; proactive toileting preempts impulsive transfers.

Independent Action

Intervention: Coach patient through the 'Sit and Dangle' rule: sit on the edge of the bed for a full 60 seconds with feet flat on the floor before rising to a stand.

Rationale: Allows carotid and aortic baroreceptors to adjust systemic vascular resistance, compensating for gravity-induced venous pooling and blunting orthostatic drops.

Collaborative Action

Intervention: Collaborate with clinical pharmacist and physician to perform Beers Criteria medication reconciliation to taper or eliminate non-essential sedating agents (e.g., zolpidem).

Rationale: Sedative-hypnotics impair psychomotor coordination, double fall risks, and precipitate paradoxical acute confusion in elderly patients.

Collaborative Action

Intervention: Consult Physical Therapy for formal gait assessment and prescription of an appropriately fitted wheeled walker.

Rationale: Assistive devices widen the base of support and offload weak lower extremities, stabilizing dynamic center of gravity during ambulation.

Patient Teaching Action

Intervention: Educate patient and family on home safety modifications: eliminating throw rugs, installing 3M non-slip shower strips, and keeping a lighted path to the bathroom.

Rationale: Eliminating trip hazards and optimizing environmental visibility directly cuts post-discharge fall rates by over 40%.

Evaluation Criteria

Psychiatric / Behavioral NANDA-I Standard

Risk for Suicide: Severe Depressive Episode

PES Statement: Risk for Suicide as evidenced by active suicidal ideation with a formulated lethal plan (overdose on hoarded prescription medications), Columba-Suicide Severity Rating Scale (C-SSRS) Level 5, pervasive hopelessness, recent loss of spouse 4 weeks ago, and sudden giving away of personal heirlooms.

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient states: 'There is no point in waking up anymore; everyone would be better off without me.'
  • Patient admits: 'I have been saving up my sleeping pills so I can end it all when no one is looking.'
Objective Cues
  • Columbia-Suicide Severity Rating Scale (C-SSRS): Level 5 (Active suicidal ideation with specific plan and intent).
  • Mood / Affect: Severe psychomotor retardation, flat blunted affect, poor eye contact, tearfulness.
  • Behavior: Gave away vintage wedding ring to neighbor 3 days prior to admission; abrupt withdrawal from all social contacts.
  • History: Major Depressive Disorder; spouse passed away 4 weeks prior; severe insomnia with early morning awakening.

NOC Expected Outcomes (SMART Goals)

  • Short-Term (Throughout Inpatient Stay): Patient will remain physically safe and free from self-directed violence or suicide attempts. Target: Zero self-harm incidents
  • Short-Term (Within 24 Hours): Patient will sign a collaborative Safety Plan, identify two personal crisis triggers, and agree to notify nursing staff immediately upon emergence of suicidal urges. Target: Signed Safety Plan, Verbalize triggers
  • Long-Term (By Discharge / Day 7): Patient will articulate three future-oriented protective factors, identify two positive coping mechanisms, and connect with outpatient psychiatric support. Target: 3 protective factors, Outpatient scheduled

NIC Interventions & Physiological Rationales

Independent Action

Intervention: Implement 1:1 Continuous Visual Observation or Q15-Minute Unpredictable Safety Checks (per physician order) with patient within arm's reach or constant visual line of sight.

Rationale: Direct continuous line-of-sight monitoring physically prevents access to self-harm means and provides immediate lifesaving intervention during high-risk acute crises.

Independent Action

Intervention: Conduct thorough Environmental Safety Sweep (strip room of all ligature points, plastic bags, phone cords, sharps, glass, metal utensils, and belts/shoelaces).

Rationale: Restricting access to lethal means is the single most empirically validated environmental intervention for reducing suicide mortality in acute facilities.

Independent Action

Intervention: Establish an empathetic, non-judgmental therapeutic alliance and ask direct, unambiguous questions about suicide ('Are you thinking of killing yourself? Do you have a plan?').

Rationale: Direct questioning does NOT plant suicidal ideas; it relieves emotional isolation, validates psychological suffering, and provides critical diagnostic clarity.

Collaborative Action

Intervention: Administer prescribed antidepressant / anxiolytic psychotropic medications (e.g., sertraline 50 mg daily, lorazepam 0.5 mg PRN acute severe agitation).

Rationale: Serotonin reuptake inhibition gradually restores synaptic monoamine neurotransmission, alleviating core depressive neurovegetative symptoms.

Collaborative Action

Intervention: Perform mouth checks ('cheek and tongue sweep') following every oral medication administration.

Rationale: Patients with suicidal intent frequently cheek and hoard sedative medications to assemble a lethal overdose bolus.

Patient Teaching Action

Intervention: Collaboratively build the Stanley-Brown Safety Plan: Identify internal warning signs, distraction coping strategies, family contacts, and provide the 988 Suicide & Crisis Lifeline number.

Rationale: A personalized written safety plan provides concrete step-by-step cognitive anchors that interrupt suicidal escalation during crisis states.

Evaluation Criteria

Metabolic / Renal NANDA-I Standard

Deficient Fluid Volume: Severe Dehydration & Hypovolemia

PES Statement: Deficient Fluid Volume related to active gastrointestinal fluid loss secondary to acute gastroenteritis and inadequate fluid intake as evidenced by resting sinus tachycardia (122 bpm), hypotension (86/52 mmHg) with orthostatic drop, sternal skin tenting > 3 seconds, oliguria (15 mL/hr) with specific gravity 1.034, and prerenal azotemia (BUN 48 mg/dL, Cr 2.1 mg/dL, ratio 22.8:1).

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient reports: "I haven't been able to keep water down for two days."
  • Patient states: "Everything spins and goes dark when I attempt to sit or stand."
Objective Cues
  • BP 86/52 mmHg supine, dropping to 72/40 sitting; HR 122 bpm sinus tachycardia.
  • Sternal skin tenting > 3 sec; parched oral mucosa with dry tongue furrows.
  • Urine output 15 mL/hr dark amber, specific gravity 1.034.
  • BUN 48 mg/dL, Creatinine 2.1 mg/dL (BUN/Cr ratio > 20:1); Serum Na+ 149 mEq/L, K+ 3.2 mEq/L.

NOC Expected Outcomes (SMART Goals)

  • Short-Term (Within 4 Hours): Mean Arterial Pressure (MAP) will stabilize >= 65 mmHg and resting HR will decrease to < 100 bpm. Target: MAP >= 65 mmHg, HR 60-99 bpm, SBP > 100 mmHg
  • Intermediate (Within 12 Hours): Urine output will reach and maintain >= 0.5 mL/kg/hr clear yellow for 6 consecutive hours. Target: Urine output >= 30 mL/hr, SpG 1.010-1.025
  • Resolution (Within 24 Hours): Serum potassium will normalize to 3.5 - 5.0 mEq/L and sodium will correct safely without rapid osmotic shifts. Target: K+ 3.5-5.0 mEq/L, Na+ 135-145 mEq/L, BUN/Cr < 20:1

NIC Interventions & Physiological Rationales

Collaborative Action

Intervention: Administer isotonic crystalloid infusion (0.9% NaCl or Lactated Ringers) at 1,000 mL bolus over 60 minutes via large-bore IV, followed by maintenance with KCl.

Rationale: Isotonic solutions expand effective circulating intravascular volume, restoring venous return to the right atrium and elevating stroke volume without shifting free water into cells.

Independent Action

Intervention: Monitor vital signs, orthostatic blood pressure, and MAP every 15 minutes during active crystalloid bolusing, transitioning to hourly once MAP >= 65 mmHg.

Rationale: Restoring MAP >= 65 mmHg ensures critical capillary hydrostatic perfusion pressure across renal glomerular filtration barriers, reversing prerenal acute tubular ischemia.

Independent Action

Intervention: Insert indwelling urinary catheter with urometer; measure and record hourly volume, color, and specific gravity.

Rationale: Hourly monitoring allows immediate titration of fluid rates. Urine volume < 0.5 mL/kg/hr signals persistent intravascular hypovolemia or progressing acute kidney injury.

Evaluation Criteria

Hydration restored when MAP >= 65 mmHg, heart rate < 100 bpm, urine output >= 0.5 mL/kg/hr, and BUN/Creatinine ratio normalizes to < 20:1 with resolution of orthostasis.

Metabolic / Renal NANDA-I Standard

Excess Fluid Volume: Acute Kidney Injury & End-Stage Renal Disease

PES Statement: Excess Fluid Volume related to severely compromised regulatory mechanisms secondary to end-stage renal disease and missed hemodialysis sessions as evidenced by bilateral pulmonary crackles, SpO2 86% on room air, 4+ lower extremity and sacral pitting edema, jugular venous distention (9 cm), volume hypertension (188/104 mmHg), and critical hyperkalemia (6.2 mEq/L) with peaked T waves.

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient states: "I feel like I am suffocating when I attempt to lie down flat."
  • Patient reports: "My legs are so swollen and heavy that my skin feels like it is tearing."
Objective Cues
  • BP 188/104 mmHg, HR 106 bpm, RR 28 breaths/min, SpO2 86% room air.
  • Bilateral coarse crackles across lower 2/3 of lung fields; audible S3 gallop.
  • 4+ lower extremity pitting edema to mid-thigh; sacral edema; JVD 9 cm at 45 deg.
  • K+ 6.2 mEq/L with peaked T waves on 12-lead ECG; BUN 84 mg/dL, Cr 7.4 mg/dL.

NOC Expected Outcomes (SMART Goals)

  • Immediate (Within 2 Hours): Myocardial resting membrane potential will be stabilized with normalization of ECG T waves. Target: Normal T waves on continuous telemetry, K+ < 5.5 mEq/L
  • Short-Term (Within 4 Hours): SpO2 will maintain >= 94% on <= 2 L/min NC with clearing of pulmonary crackles. Target: SpO2 >= 94%, RR 14-20 breaths/min, clear lung bases
  • Resolution (Within 8 Hours): Blood pressure will decrease to < 140/90 mmHg following hemodialysis ultrafiltration. Target: BP < 140/90 mmHg, Net ultrafiltration 2.5 - 3.5 kg

NIC Interventions & Physiological Rationales

Collaborative Action

Intervention: Administer IV Calcium Gluconate (1 g over 3-5 min), followed by Regular Insulin (10 units IV) with 50 mL D50W, and nebulized Albuterol (15 mg).

Rationale: Calcium gluconate stabilizes myocardial resting membrane potential against fatal arrhythmias. Insulin and beta-2 agonists drive extracellular potassium into cells via Na+/K+ ATPase activation.

Independent Action

Intervention: Position patient in High-Fowler position (90 degrees) with dependent legs; apply supplemental oxygen.

Rationale: Dependent leg positioning pools venous blood peripherally, decreasing preload to the overwhelmed right ventricle and maximizing lung surface area for gas exchange.

Collaborative Action

Intervention: Coordinate emergent hemodialysis / ultrafiltration; verify arteriovenous fistula patency (thrill and bruit).

Rationale: Mechanical ultrafiltration extracts excess intravascular hydrostatic volume and clears toxic metabolic acids when renal filtration is absent.

Evaluation Criteria

Euvolemia restored post-dialysis with dry weight achieved, BP < 140/90 mmHg, lungs clear bilaterally, and potassium normalized to 3.5 - 5.0 mEq/L.

Endocrine / Metabolic NANDA-I Standard

Unstable Blood Glucose Level: Diabetic Ketoacidosis (DKA)

PES Statement: Unstable Blood Glucose Level related to absolute insulin deficiency secondary to insulin pump failure as evidenced by blood glucose 540 mg/dL, arterial pH 7.14, serum bicarbonate 7 mEq/L, beta-hydroxybutyrate 6.8 mmol/L, anion gap 26 mEq/L, Kussmaul respirations (34 breaths/min), and hypovolemic dehydration (BP 94/58 mmHg, HR 128 bpm).

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient reports severe diffuse abdominal pain, nausea, and continuous vomiting.
  • Patient states: "My insulin pump stopped working yesterday and I didn't have extra pens."
Objective Cues
  • Point-of-care glucose 540 mg/dL; beta-hydroxybutyrate 6.8 mmol/L; anion gap 26 mEq/L.
  • ABG: pH 7.14, PaCO2 18 mmHg, HCO3- 7 mEq/L (severe uncompensated ketoacidosis).
  • Kussmaul respirations (34 breaths/min) with prominent fruity acetone breath odor.
  • BP 94/58 mmHg, HR 128 bpm; desiccated mucous membranes; Serum K+ 5.4 mEq/L.

NOC Expected Outcomes (SMART Goals)

  • Short-Term (Hourly): Blood glucose will decrease at a steady, controlled rate of 50-75 mg/dL/hr. Target: Rate of glucose decline 50-75 mg/dL/hr
  • Intermediate (Within 8 Hours): Blood glucose will reach 150-200 mg/dL and IV fluids will transition to D5 1/2NS. Target: Glucose 150-200 mg/dL, zero hypoglycemic events
  • Resolution (Within 16 Hours): Anion gap will close (<= 12 mEq/L) and venous pH will normalize to > 7.30. Target: Anion gap <= 12 mEq/L, HCO3 >= 18 mEq/L, pH > 7.30

NIC Interventions & Physiological Rationales

Collaborative Action

Intervention: Infuse 0.9% NaCl IV at 1,000 mL/hr for the initial 1-2 hours; switch to 0.45% NaCl once hemodynamics stabilize and corrected sodium is verified.

Rationale: Restoring intravascular volume treats prerenal shock, clears glucosuria, and reduces counter-regulatory stress hormones. Insulin without volume resuscitation precipitates circulatory collapse.

Collaborative Action

Intervention: Initiate regular insulin continuous IV infusion at 0.1 units/kg/hr; add 5% dextrose (D5 1/2NS) when glucose reaches 200-250 mg/dL.

Rationale: Insulin suppresses lipolysis and hepatic ketogenesis. Adding dextrose prevents hypoglycemia while allowing insulin to remain running until ketoacidosis is fully eradicated.

Independent Action

Intervention: Perform hourly neurological checks and Glasgow Coma Scale assessments; monitor for headache, bradycardia, or sudden lethargy.

Rationale: Rapid reduction in serum osmolality (> 75-100 mg/dL/hr glucose drop) creates an osmotic gradient shifting free water into brain cells, precipitating fatal cerebral edema.

Evaluation Criteria

Ketoacidosis fully resolved when blood glucose is 150-200 mg/dL, serum bicarbonate >= 18 mEq/L, venous pH > 7.30, and anion gap is closed with tolerance of oral intake.

Gastrointestinal / Nutrition NANDA-I Standard

Imbalanced Nutrition: Post-Stroke Dysphagia & Cachexia

PES Statement: Imbalanced Nutrition: Less Than Body Requirements related to impaired swallowing ability secondary to cerebrovascular accident as evidenced by 15.9% unintentional weight loss over 60 days, BMI 16.8 kg/m2, video fluoroscopic confirmation of silent tracheal aspiration, prealbumin 8.4 mg/dL, and visible temporal muscle wasting.

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient states: "Food feels like it gets caught in my throat, so I give up on eating."
  • Patient reports coughing and choking whenever attempting to drink liquids.
Objective Cues
  • Current weight 41.2 kg down from 49.0 kg (15.9% weight loss); BMI 16.8 kg/m2.
  • Temporal wasting, hollow supraclavicular fossae, loss of subcutaneous fat stores.
  • VFSS confirms silent aspiration of thin liquids and pooling in valleculae.
  • Serum prealbumin 8.4 mg/dL, albumin 2.6 g/dL, total lymphocyte count 850/uL.

NOC Expected Outcomes (SMART Goals)

  • Short-Term (Within 24 Hours): Patient will experience zero episodes of coughing, choking, or tracheal aspiration. Target: Clear breath sounds, SpO2 >= 95% RA, no wet vocal quality
  • Intermediate (Within 7 Days): Patient will meet 100% of calculated caloric requirements (1,500 kcal/day, 50 g protein) via enteral feeding. Target: Caloric intake 100% of goal, prealbumin > 12 mg/dL
  • Long-Term (Within 30 Days): Patient will achieve steady weight stabilization and gain of 0.5 - 1.0 lb/week. Target: Weight gain 0.5-1.0 lb/week, BMI > 18.0 kg/m2

NIC Interventions & Physiological Rationales

Independent Action

Intervention: Maintain strict NPO for standard oral intake; provide oral hygiene with chlorhexidine swabs Q4H.

Rationale: When epiglottic closure is impaired, oral feeding leads directly to bacterial aspiration pneumonia, chemical pneumonitis, and respiratory failure.

Collaborative Action

Intervention: Initiate continuous enteral tube feeding via small-bore NG tube at 20 mL/hr, advancing by 10-20 mL/hr Q12H to goal rate of 60 mL/hr; keep HOB >= 30-45 degrees.

Rationale: Enteral nutrition preserves gut mucosal barrier integrity and delivers sustained calories. HOB elevation utilizes gravity to prevent passive retrograde esophageal aspiration.

Independent Action

Intervention: Monitor baseline and daily serum phosphorus, potassium, and magnesium for the first 72 hours of refeeding.

Rationale: Refeeding starved patients triggers massive insulin release, shifting phosphate into cells to produce ATP and causing fatal hypophosphatemic cardiac arrest (refeeding syndrome).

Evaluation Criteria

Nutritional adequacy demonstrated when target caloric goal (1,500 kcal/day) is tolerated enterally, serum prealbumin rises > 15 mg/dL, and weight stabilizes without refeeding syndrome.

Gastrointestinal / Infection Control NANDA-I Standard

Diarrhea: Clostridioides difficile Colitis

PES Statement: Diarrhea related to enteric dysbiosis and Clostridioides difficile toxin-mediated colonic mucosal inflammation secondary to broad-spectrum antibiotic therapy as evidenced by frequent watery unformed stools (>= 8 episodes/12 hr), positive stool C. diff PCR and toxin EIA, leukocytosis (18,400/uL), lower abdominal cramping, and perianal skin excoriation.

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient reports 8 episodes of watery, foul-smelling diarrhea since this morning.
  • Patient states: "The cramping in my lower belly is awful, and my bottom is burning."
Objective Cues
  • 8 loose watery stools in 12 hours; stool PCR and EIA positive for C. diff toxins.
  • WBC 18,400/uL; Serum Cr 1.6 mg/dL (baseline 0.9 mg/dL, severe infection criteria).
  • T 38.4C, HR 108 bpm, BP 102/62 mmHg; hyperactive bowel sounds in all quadrants.
  • Perianal erythema with partial-thickness skin excoriation (incontinence-associated dermatitis).

NOC Expected Outcomes (SMART Goals)

  • Short-Term (Within 24 Hours): Fluid and electrolyte balance will be maintained without progression of prerenal azotemia. Target: Serum K+ >= 4.0 mEq/L, Cr < 1.2 mg/dL, urine output >= 30 mL/hr
  • Intermediate (Within 72 Hours): Stool frequency will decrease to <= 3 semi-formed bowel movements per 24 hours. Target: <= 3 stools/day, Bristol Stool Scale Type 4-5
  • Resolution (Within 5 Days): Perianal erythema and skin excoriation will re-epithelialize without fungal infection. Target: Perianal skin intact, pain score 0/10

NIC Interventions & Physiological Rationales

Independent Action

Intervention: Place patient on strict Contact Plus Precautions in a private room; wash hands exclusively with soap and water (NOT alcohol rub); disinfect surfaces with sporicidal bleach.

Rationale: C. diff spores are resistant to alcohol-based sanitizers. Mechanical friction with soap and water is required to physically remove spores from hands.

Collaborative Action

Intervention: Administer Oral Vancomycin (125 mg PO Q6H) as scheduled for 10 days; hold all anti-motility drugs (loperamide).

Rationale: Oral vancomycin is not absorbed systemically, achieving massive luminal concentrations to kill vegetative bacteria. Anti-motility agents trap toxins in the bowel, risking toxic megacolon.

Independent Action

Intervention: Cleanse perianal skin with no-rinse perineal cleanser post-stooling; apply thick layer of dimethicone or zinc oxide barrier paste.

Rationale: Diarrheal stool contains pancreatic digestive enzymes that chemically digest the epidermal stratum corneum, creating painful denudation.

Evaluation Criteria

Colitis resolved when stool frequency returns to patient baseline (< 3/day), WBC count normalizes (< 10,000/uL), creatinine returns to baseline, and abdominal cramping is absent.

Gastrointestinal NANDA-I Standard

Constipation & Fecal Impaction: Opioid-Induced Bowel Dysfunction

PES Statement: Constipation related to opioid-induced bowel hypomotility, surgical immobility, and decreased fluid intake as evidenced by absence of formed defecation for 5 consecutive post-operative days, hard immovable fecal mass palpated in rectal vault, paradoxical liquid stool encopresis, abdominal distention, and hypoactive bowel sounds.

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient reports: "I feel completely blocked up, bloated, and nauseated."
  • Patient states: "I feel constant rectal pressure, but only small amounts of brown water leak out."
Objective Cues
  • No formed bowel movement for 5 days post total hip arthroplasty on scheduled oxycodone.
  • Digital rectal exam confirms large, rock-hard fecal mass filling the rectal ampulla.
  • Paradoxical liquid fecal seepage leaking around impaction onto chux pad.
  • KUB abdominal X-ray confirms heavy fecal loading; hypoactive bowel sounds (1 click/min).

NOC Expected Outcomes (SMART Goals)

  • Immediate (Within 6 Hours): Patient will successfully evacuate the impacted fecal mass following disimpaction and enema. Target: Evacuation of hard fecalith, rectal vault empty on exam
  • Short-Term (Within 24 Hours): Abdominal distention, nausea, and rectal urgency will completely resolve. Target: Abdomen soft, non-distended, normoactive bowel sounds in 4 quadrants
  • Maintenance (Throughout Admission): Patient will maintain soft, formed bowel movement every 1-2 days on scheduled bowel regimen. Target: Bristol Stool Scale Type 4 stool Q1-2 days without straining

NIC Interventions & Physiological Rationales

Independent Action

Intervention: Perform gentle digital disimpaction using lubricated, gloved finger with topical lidocaine; monitor heart rate continuously.

Rationale: Large rock-hard fecaliths cannot pass through the sphincter and obstruct oral laxatives. Digital stimulation can trigger the rectal vagal reflex, causing profound bradycardia and syncope.

Collaborative Action

Intervention: Instill oil retention enema (100-150 mL) retained for 30 minutes, followed by warm water cleansing enema.

Rationale: Mineral oil softens hardened desiccated stool and lubricates the rectal mucosal wall, preventing mucosal tears during evacuation.

Collaborative Action

Intervention: Initiate multimodal bowel regimen: Senna (17.2 mg PO BID) plus Polyethylene Glycol (17 g PO daily) plus Docusate (100 mg PO BID).

Rationale: Stimulants overcome opioid mu-receptor peristaltic inhibition; osmotic agents draw water into colonic lumen. "Mush without push" (softeners alone) fails in opioid therapy.

Evaluation Criteria

Bowel regularity restored when patient evacuates soft formed stool without digital assistance, bowel sounds are normoactive, and abdominal distention is absent.

Neurological / Cognitive NANDA-I Standard

Acute Confusion: Nocturnal Delirium Superimposed on Dementia

PES Statement: Acute Confusion related to acute systemic urinary tract infection, anticholinergic medication exposure, and sensory deprivation superimposed on vascular dementia as evidenced by sudden nocturnal agitation, visual hallucinations, positive Confusion Assessment Method (CAM) score, severe inattention, urinary retention (520 mL), and fever (38.1C).

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient screams: "Get these people away from me! Let me out of this jail!"
  • Family reports: "He has mild baseline memory loss, but he was completely calm and knew us yesterday."
Objective Cues
  • CAM score positive in all 4 features (acute onset, fluctuating course, inattention, altered consciousness).
  • Sudden nocturnal agitation at 02:00, picking at IV, climbing bed rails, visual hallucinations.
  • Bladder scan reveals 520 mL urinary retention; UA positive for nitrites/LE; T 38.1C, HR 104.
  • Received IV diphenhydramine 50 mg at 22:00 (high-risk anticholinergic trigger).

NOC Expected Outcomes (SMART Goals)

  • Immediate (Within 4 Hours): Acute urinary retention will be relieved and combative panic de-escalated without physical restraints. Target: Bladder volume < 100 mL post-cath, patient calm in bed
  • Short-Term (Within 24 Hours): Patient will return to negative CAM score and baseline conversational orientation. Target: CAM negative, oriented to person and family
  • Safety (Throughout Admission): Zero falls, line dislodgments, or physical restraint usage. Target: Zero falls, restraints not utilized

NIC Interventions & Physiological Rationales

Independent Action

Intervention: Perform straight catheterization to relieve acute urinary retention; send sterile urine culture and initiate prescribed IV Ceftriaxone.

Rationale: Bladder distention triggers sympathetic C-fiber firing and severe delirium. Eradicating the underlying infection eliminates the primary neuroinflammatory drive.

Collaborative Action

Intervention: Discontinue diphenhydramine, benzodiazepines, and high-potency opioids; transition pain regimen to scheduled acetaminophen.

Rationale: Anticholinergic agents block central muscarinic M1 receptors in the hippocampus, directly triggering acute delirium and hallucinations in elderly patients.

Independent Action

Intervention: Implement non-pharmacologic delirium bundle: ensure glasses/hearing aids are worn, provide calm re-orientation, open blinds during day, dim lights at night, lower bed to floor with mat.

Rationale: Sensory re-anchoring and circadian rhythm restoration prevent sensory deprivation hallucinations without the high mortality of physical restraints.

Evaluation Criteria

Delirium resolved when CAM evaluation is negative, patient recognizes familiar caregivers, diurnal sleep-wake cycle is restored, and underlying infection is eradicated.

Neurological NANDA-I Standard

Impaired Verbal Communication: Post-Stroke Broca's Aphasia

PES Statement: Impaired Verbal Communication related to ischemic injury to the speech-motor execution center (Broca's area) secondary to left middle cerebral artery stroke as evidenced by halting non-fluent telegraphic speech, severe frustration and weeping during communication attempts, preserved auditory comprehension, and right facial weakness.

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient points to mouth and throat, weeping in visible frustration.
  • Writes on pad with left hand: "I know... words... won't come."
Objective Cues
  • Effortful, halting single-word speech production; severe speech apraxia.
  • Auditory comprehension 100% intact (follows complex 3-step commands accurately).
  • Right facial flattening and right hemiparesis (arm 1/5, leg 3/5).
  • MRI confirms acute left inferior frontal gyrus infarction (Broca's area).

NOC Expected Outcomes (SMART Goals)

  • Short-Term (Within 48 Hours): Patient will express urgent physical needs and pain ratings using a picture communication board with 100% accuracy. Target: Picture board utilized for 100% of toileting, pain, and water requests
  • Emotional (Within 5 Days): Patient will demonstrate reduction in situational frustration and weeping during care interactions. Target: Zero tearful episodes during routine shift assessments
  • Rehabilitation (Within 14 Days): Patient will participate actively in Speech Therapy Melodic Intonation Therapy (MIT). Target: Successful vocalization of basic functional phrases via melody

NIC Interventions & Physiological Rationales

Independent Action

Intervention: Place personalized picture/word communication board and electronic tablet within reach of functional left hand.

Rationale: Broca's aphasia impairs motor speech programming while cognitive intellect remains intact. Visual icons allow immediate communication without vocal cord exhaustion.

Independent Action

Intervention: Ask simple, structured closed-ended "yes/no" questions; allow >= 15-30 seconds processing time; avoid rushing or finishing sentences.

Rationale: Rushing the patient or completing their sentences triggers profound helplessness and demoralization. Structured questions reduce cognitive motor load.

Collaborative Action

Intervention: Collaborate with Speech-Language Pathology to implement Melodic Intonation Therapy (MIT) techniques.

Rationale: Language is left-hemispheric, but melody and rhythm are mediated by homologous right-hemisphere circuits. Singing phrases bypasses damaged left Broca area.

Evaluation Criteria

Functional communication achieved when patient successfully communicates physical needs, pain, and choices via augmentative picture board or melodic phrases without emotional distress.

Neurological / Safety NANDA-I Standard

Risk for Injury: Generalized Tonic-Clonic Seizure Precautions

PES Statement: Risk for Injury as evidenced by abrupt cessation of prescribed anticonvulsant therapy with subtherapeutic blood levels (< 2.0 mcg/mL), active premonitory epigastric sensory aura, and abnormal EEG showing paroxysmal spike-and-wave epileptiform discharges.

Assessment Cues (Subjective & Objective)

Subjective Data
  • Patient admits: "I ran out of my Keppra four days ago because I couldn't afford the copay."
  • Patient reports experiencing rising stomach flutter and flashing lights (sensory aura).
Objective Cues
  • Serum levetiracetam level < 2.0 mcg/mL (therapeutic range 12 - 46 mcg/mL).
  • Continuous video-EEG demonstrates high-voltage paroxysmal spike-and-wave discharges.
  • Active sensory aura reported by patient.
  • High risk for generalized tonic-clonic convulsions, hypoxia, and physical injury.

NOC Expected Outcomes (SMART Goals)

  • Immediate (Within 12 Hours): Therapeutic anticonvulsant blood levels will be restored via IV loading dose. Target: Levetiracetam level 12-46 mcg/mL, zero breakthrough seizures
  • Safety (Throughout Admission): Zero physical injuries (fractures, lacerations, burns, aspiration) sustained during any seizure episode. Target: Zero physical injuries recorded
  • Education (Prior to Discharge): Patient will identify community copay assistance and verbalize dangers of abrupt anticonvulsant cessation. Target: Enrolled in patient assistance program, verbalizes 100% adherence rationale

NIC Interventions & Physiological Rationales

Independent Action

Intervention: Pad side rails with fitted seizure pads; ensure functional suction canister with rigid Yankauer tip and oxygen flowmeter with NRB mask are verified at bedside. Keep bed in lowest position.

Rationale: Padded rails prevent fractures and soft tissue contusions during forceful involuntary contractions. Immediate suction prevents fatal aspiration of pooled oral secretions during post-ictal coma.

Independent Action

Intervention: During an active seizure: ease patient to side-lying (lateral recumbent) position; pad head; loosen collar; NEVER insert any object into mouth; time duration precisely.

Rationale: Lateral positioning allows secretions and emesis to drain by gravity, maintaining upper airway patency. Forcing objects into the mouth fractures teeth and causes airway obstruction.

Collaborative Action

Intervention: If seizure activity persists >= 5 minutes (Status Epilepticus), immediately administer IV Lorazepam (4 mg IV push over 2 min); infuse IV Levetiracetam (1,500 mg IV piggyback over 15 min).

Rationale: After 5 minutes, endogenous seizure termination fails. Benzodiazepines activate GABAA receptors to halt propagation, preventing excitotoxic neuronal apoptosis.

Evaluation Criteria

Seizure control maintained with therapeutic anticonvulsant serum levels, zero physical trauma, patent airway maintained throughout post-ictal recovery, and copay assistance secured.

Done-For-You Clinical Resource Bundles

Stop Spending 5 Hours Every Sunday Hand-Typing Care Plans

Download 100+ pre-formatted, instructor-approved care plans with cellular-level rationales and APA citations already written in editable Microsoft Word (.docx) and Google Docs.

Standard Tier

Done-For-You Care Plan Vault

The complete editable Word & Google Docs library for fast, stress-free clinical submission.

$ 27 one-time payment
  • ✓ 100+ Full ADPIE Care Plans across all 10 clinical specialties
  • ✓ Microsoft Word (.docx) & Google Docs fully editable files
  • ✓ 3-Column, 4-Column & Concept Map nursing school rubrics
  • ✓ Cellular-Level Rationales pre-written & instructor-proofed
  • ✓ Pre-Formatted APA Citations included for every intervention
  • ✓ Instant digital ZIP download + lifetime cloud drive access
Get the $27 Word Vault → 🔒 30-Day 100% Instructor-Approved Guarantee
🎁

Not ready to buy? Download the Free Clinical Shift Starter Kit

Get the Printable SBAR Handoff Sheet + 3-Patient Med-Surg Brain Sheet (Free PDF Download).